Tampa General Hospital is a 1,041-bed non-profit, tertiary, research and academic medical center located on Davis Island in Tampa, Florida, servicing western Florida and the greater Tampa Bay region. TGH is one of the region's only university-level academic medical centers.

There are 1,041 beds in Tampa General Hospital.

During the past decade, Tampa General Hospital conducted 154 clinical trials. In the 10-year time frame, 154 clinical trials started and 92 clinical trials were completed, i.e. on average, 59.7% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 45 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tampa General Hospital" #1 sponsor was "Children's Oncology Group" with 36 trials, followed by "University of South Florida" with 34 trials sponsored, "National Cancer Institute (NCI)" with 18 trials sponsored, "Abbott Medical Devices" with 16 trials sponsored and "Gilead Sciences" with 16 trials sponsored. Other sponsors include 196 different institutions and companies that sponsored additional 134 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tampa General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 43 trials as a collaborator, "Tampa General Hospital" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Thoratec Corporation" with 4 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 3 trials as a collaborator. Other collaborators include 132 different institutions and companies that were collaborators in the rest 121 trials.

According to Clinical.Site data, the most researched conditions in "Tampa General Hospital" are "Heart Failure" (11 trials), "Burns" (8 trials), "Malignant Solid Neoplasm" (8 trials), "Acute Lymphoblastic Leukemia" (5 trials) and "Acute Myeloid Leukemia" (5 trials). Many other conditions were trialed in "Tampa General Hospital" in a lesser frequency.

Most popular intervention types in "Tampa General Hospital" are "Drug" (139 trials), "Device" (91 trials), "Other" (79 trials), "Procedure" (50 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "Laboratory Biomarker Analysis" (24 trials), "Questionnaire Administration" (18 trials), "Cyclophosphamide" (16 trials) and "Biospecimen Collection" (13 trials). Other intervention names were less common.

The vast majority of trials in "Tampa General Hospital" are 301 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 105 active trials in "Tampa General Hospital". 3 are not yet recruiting, 58 are recruiting, 41 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 142 completed trials in Tampa General Hospital, 4 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Tampa General Hospital, 9 "Phase 1" clinical trials were conducted, 62 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 92 trials that are defined as “Not Applicable".

Tampa General Hospital has several departments that took part in Clinical trials: "Tampa Children's Hospital" - 14 trials, "Tampa General Hospital Cardiac and Lung Transplant Clinic" - 5 trials, "Florida Orthopaedic Institute- Tampa General Hospital" - 3 trials